AB-02-TI14_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (R)-N-[2-Chloro-4-(piperazinosulfonyl)phenyl]-2-methyl-2-hydroxy-3,3,3-trifluoropropionamide, Pyruvate Dehydrogenase Kinase (PDHK;PDK) Inhibitors targeting PDK2, PDK3, PDK4 (Novartis, 10387163)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10387163
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the AB-02-TI14_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CCT7 chaperonin containing TCP1, subunit 7 (eta) 0.950778
APRT adenine phosphoribosyltransferase 0.868212
KIAA1210 KIAA1210 0.765005
THOC6 THO complex 6 0.743165
PYY peptide YY 0.457301
RPS16 ribosomal protein S16 0.31119
VPS28 vacuolar protein sorting 28 homolog (S. cerevisiae) 0.31119
MYL2 myosin, light chain 2, regulatory, cardiac, slow 0.29644
PGP phosphoglycolate phosphatase 0.256345
COX5B cytochrome c oxidase subunit Vb 0.222671
CDC20 cell division cycle 20 0.207541

decreased expression

Symbol Name Standardized Value
PSMD14 proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 -0.30288
KLHDC4 kelch domain containing 4 -0.247479
RPL32 ribosomal protein L32 -0.247479